LSE:AZN
LSE:AZNPharmaceuticals

AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination

AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important milestone for easier access to vaccinations in 34 U.S. states. This initiative likely contributed to its stock price increase of 12% last quarter, as it aligns with AstraZeneca's push towards innovative healthcare solutions. Despite this positive development, the overall market also experienced an upward trend, with the Dow hitting record highs and the market up 1% over the...